{"prompt": "['activated B cells (NFKb) pathway to increase transcription of proteins involved in cell proliferation,', 'inflammation and anti-apoptosis. In addition, activation of NFkb is implicated in prostate cancer,', 'nuclear expression being associated with nodal metastasis. 16 IL-6 and TNFa are both elevated in', 'the', 'serum of patients with metastatic carcinoma compared to patients without metastases. Interestingly,', 'both are elevated in prostate carcinoma in direct proportion to disease stage, 17 and increases occur', 'at the time of biochemical (PSA) disease progression.', '3) Energy Metabolism - Exercise improves insulin sensitivity and glucose metabolism. While ADT', 'in', 'principle is targeting the prostate cancer tumour, the systemic treatment in patients results in a range', 'of', 'alterations associated with metabolic syndrome. 18 One of the earliest changes following ADT, within', '2-6 weeks, is a reduction in insulin sensitivity leading to a rise in circulating insulin (hyperinsulinemia);', 'the rise in insulin levels precedes changes in adiposity and increased lipids, sarcopenia, and bone', 'loss.', '18,19 High insulin levels are predictive of more rapid progression to CRPC, and poor', 'prognosis. 19,20 Insulin has been shown to have a direct action on prostate cancer growth and', 'progression, and this can be inhibited by blocking insulin action.21 Additionally, high levels of', 'C-', 'peptide, a marker of insulin secretion, are associated with a more than 2-fold increased risk of prostate', 'cancer-specific mortality. 20 Further, overweight (body mass index (BMI) >25 kg/m\u00b2) men with high C-', 'peptide levels had a more than 4-fold increased risk of prostate cancer-specific mortality compared', 'to normal weight men with low C-peptide levels.', '4) Body composition - Cancer and its treatments cause substantial changes in body composition with', 'sarcopenic obesity being a common outcome. This not only results in substantial impediment to', 'functional ability and increased cardio-metabolic risk, but also alteration of adipokine and myokine', 'balance, which may contribute to tumour progression. Exercise increases lean muscle mass and may', 'cause loss of fat mass, thereby improving overall body composition.', '5) Epigenetics - Exercise can produce epigenetic modulations that may inhibit tumour cell proliferation,', 'such as altering histone deacetylase pathways.', '6) Telomere - Short and/or variable telomere length in the prostate is a prognostic marker among men', 'with prostate cancer. One study among 10 men with localised prostate cancer on active surveillance', 'reported that a lifestyle program that included moderate exercise (as well as diet, stress management,', 'and social support) increased telomere length in blood.22', '7) Cholesterol - Epidemiological studies have suggested that high levels of cholesterol in the blood are', 'associated with increased risk of prostate cancer and progression of prostate cancer. 23,24 Exercise', 'combined with dietary modification has been demonstrated to substantially reduce total cholesterol', 'as well as improve the ratio of high density lipoprotein to low density lipoprotein cholesterol.', '8) Oxidative stress - Exercise has been demonstrated to modulate oxidative stress and improve', 'antioxidant capacity. In a pilot study at the University of California, San Francisco, men with low risk,', 'localised prostate cancer who reported >3 hours/week of vigorous physical activity had modulated', 'expression of the nuclear factor erythroid 2-related factor 2 (Nrf-2) mediated oxidative stress', 'response pathway in their normal prostate tissue compared to men who did less exercise.25 Oxidative', 'stress is hypothesized to play a significant role in the initiation and progression of prostate cancer. 26', '1.3 Randomised Controlled Trials of Exercise Among Men with Prostate Cancer', 'To date, there have been 21 exercise clinical trials conducted among men with localised prostate cancer', 'treated via radiation, surgery, or watchful waiting and 13 among men with non-metastatic prostate cancer', 'treated with primary ADT; 27-32 however, none have reported on a survival endpoint. Due to the long survival', 'of men with prostate cancer, randomised controlled trials (RCTs) must enrol men with metastatic disease in', 'order to examine a survival endpoint. However, evidence is extremely limited on the effects of exercise', 'among men with metastatic prostate cancer. Only one small pilot study to date conducted in Australia by RU', 'Newton and colleagues included men with metastatic prostate cancer. This 12-week pilot RCT of resistance', 'training versus usual care among 20 men with prostate cancer bone metastases observed no skeletal', 'complications, high attendance (83%) and tolerance (mean=6; scale: 1-7 with 7=highly tolerable), and', 'improved physical function. 32 This trial did not examine the effect of exercise on prognostic biomarkers,', 'progression, or survival, nor did it examine the combined effect of aerobic and resistance exercise. We are', 'aware of one on-going study examining the effect of supervised exercise on cardiorespiratory fitness among', 'men with castrate-resistant prostate cancer (CRPC) on enzalutamide (personal communication LW Jones to', 'JM Chan). The proposed study would be the first RCT to examine the effect of exercise on overall', 'survival (OS) in men with prostate cancer.', 'INTERVAL Protocol Version 4.0, 19 April 2018', '10']['1.4 Exercise and Quality of Life (QOL) in Men with Advanced Prostate Cancer', 'As the burden of disease among men with prostate cancer advances, a rapid, significant deterioration in QOL', 'is observed. 33 Bone pain which is reported in up to 80% of patients with metastatic disease throughout their', 'treatment, makes the largest single contributor to QOL deterioration in this population. 34 Other symptoms', 'which compromise QOL include urinary frequency, sexual dysfunction, nausea and vomiting, loss of appetite', 'and dyspnoea. 33 The benefits of exercise training on QOL for men with non-metastatic prostate cancer are', 'well described, 5,35 and include improvements in general QOL and also cancer-specific concerns including', 'fatigue and sexual health. However, whether exercise can improve QOL among men at the end stage of this', 'disease is not known.', 'Metastatic spread of prostate cancer occurs primarily to sites in the axial skeleton including the femur, pelvis', 'and vertebrae. Metastatic lesions, which are typically osteoblastic, lead to significant bone pain and', 'compromised skeletal quality. Skeletal complications, such as bone fractures, orthopaedic intervention or', 'spinal cord compression, which develop due to bone metastases, result in significant patient morbidity and', 'compromised QOL. Furthermore, compared to those who do not experience a symptomatic skeletal related', 'event (SSE), the occurrence of a SSE is associated with increased patient mortality. 36 A modular multi-modal', 'approach to exercise training involving individualised prescription of exercise to reduce the forces going', 'through the bone has been shown to be safe and feasible in men with bony metastases and not associated', 'with', 'increased risk of pathological fracture.32 This proposal will test whether exercise training delays time to', 'SSE as well as time to progression of pain and affects measures of pain severity and opiate use. Control or', 'relief of pain and delay or prevention of SSE are both indications for approved therapeutic agents for men', 'with metastatic prostate cancer.37', 'In addition to SSE and pain due to the infiltration of metastatic prostate cancer in bone, men with this disease', 'also experience debilitating cancer-related fatigue and adverse cardio-metabolic health as a side effect of', 'therapy. 6,7 Cancer-related fatigue is a distinct phenomenon from fatigue experienced by healthy individuals', 'and significantly lowers health-related QOL. There are extensive data to support that exercise improves', 'fatigue in men with a lower disease burden. 38-41 This proposal will be the first to examine whether exercise', 'improves or delays onset of cancer-related fatigue in men with metastatic prostate cancer.', '1.5 Rationale for Focus on Metastatic Castrate-Resistant Prostate Cancer (MCRPC)', 'Our', 'overarching', 'objective is to determine the effect of exercise on overall survival among men with advanced', 'prostate cancer. We have chosen to restrict our study population to men with progressive MCRPC because:', '1) Men with progressive MCRPC are at high risk for death within a time frame that can be feasibly tested in', 'the setting of a RCT (median OS on treatment = 3242 to 3543 months). 2) With the proper use of stratification', 'variables (treatment and study site), it is possible to define a homogenous study population in terms of risk', 'of death; 3) This is the largest group of patients that can be uniformly considered to have advanced prostate', 'cancer and thus provides the largest patient pool for recruitment while also meeting criteria 1 & 2; 4) while', 'new therapies for MCRPC extend life, 44,45 they also cause significant harm to metabolic and cardiac function', 'and health-related QOL which may be attenuated or avoided through exercise; and 5) we hypothesize that', 'exercise will have the largest measurable effect on OS among men with documented evidence of progressing', 'MCRPC (in contrast to men with stable M1 CRPC, non-castrate resistant disease, or non-metastatic disease).', '1.6 Rationale for Overall Survival (OS) as the Primary Endpoint', 'The primary endpoint for this randomised controlled trial will be overall survival (OS). OS was chosen as the', 'primary endpoint because it has clear biological, clinical and public health significance and is a validated', 'endpoint for approval of new treatments among men with MCRPC. Additionally, OS data can be obtained', 'with minimal loss to follow-up through review of medical and death records. The median OS among men with', 'MCRPC is 3242 to 3543 months. Thus, OS is a feasible outcome to examine within the budget and timeline of', 'the proposed study.', '1.7 Study Design', 'There is compelling biological and clinical rationale for including exercise in the clinical management of men', 'with MCRPC. We propose that psychosocial support plus exercise will increase OS compared to', 'psychosocial support alone. This will be a phase III RCT of high intensity aerobic and resistance exercise', 'training among men with MCRPC. The first twelve cycles (1 cycle=28 days) of training will be done under', 'supervision which will include a structured period of tapered supervision to self-managed exercise; the', 'training program will be self-maintained with text messages and in-person sessions to support self-', 'maintenance for an additional 12 cycles.', 'INTERVAL Protocol Version 4.0, 19 April 2018', '11']\n\n###\n\n", "completion": "END"}